Daily Archives: July 25, 2022

Kate Moss testified during the Johnny Depp-Amber Heard defamation trial in May to dispute rumors that the actor had once kicked her down the stairs. (Photo: REUTERS/Evelyn Hockstein/Pool)

Kate Moss is sharing why she testified in support of former boyfriend Johnny Depp during his defamation trial against ex-wife Amber Heard. In May the British supermodel appeared via video link to dispute rumors, which Heard referenced in her own testimony, that Depp had pushed her down some stairs during their relationship, which last from 1994 to 1998.

I believe in the truth and I believe in fairness and justice," Moss, 48, said during her appearance on the BBC Radio 4 program Desert Islands Discs on Sunday, per the Sunday Times.

I know the truth about Johnny," she continued. I know he never kicked me down the stairs. I had to say that truth."

Called as rebuttal witness by Depp's legal team, Moss explained the incident that sparked the rumors that the actor, now 59, had gotten violent during their stay at the Goldeneye Resort in Jamaica.

"We were leaving the room and Johnny left the room before I did," she told the court, noting that there had been a rainstorm.

"As I left the room I slid down the stairs and I hurt my back," she went on. "And I screamed because I was in I didn't know what had happened to me and I was in pain. He came running back to help me and carried me to my room and got me medical attention."

Moss testified that Depp "never pushed me, kicked me or threw me down any stairs" at any point during their relationship.

Moss and Depp dated from 1994 to 1998. (Photo: PATRICK HERTZOG/AFP via Getty Images)

The jury ultimately ruled in Depp's favor, awarding the actor $10.35 million in damages. Last week Heard's legal team filed to appeal the verdict, while Depp is seeking to throw out the $2 million the jury awarded his actress ex-wife stemming from one count of her countersuit accusing him of making defamatory claims against her.

In her Desert Islands Discs interview, Moss also spoke about being a "scapegoat" for the heroin-chic trend, the highs and lows of her modeling career and her defense of another notable figure: fashion designer John Galliano, who was ousted from Dior in 2011 after a video of him making anti-semitic remarks while drinking at a Paris bar went viral.

Story continues

"I know that John Galliano is not a bad person. He had an alcohol problem, and people turn, Moss said. People arent themselves when they drink, and they say things that they would never say when they were sober.

Moss has had her own brush with scandal, losing out on modeling contracts after she was photographed using cocaine in 2005.

I felt sick and was quite angry because everybody I knew took drugs," said Moss, who went to rehab and has abstained from drinking for the past four years. "For them to focus on me and try to take my daughter away was really hypocritical."

See the original post here:

Kate Moss explains why she testified in the Johnny Depp-Amber Heard trial: 'I know the truth about Johnny' - Yahoo Entertainment

LOS ANGELES In May, Major League Baseball agreed to settle an 8-year-old lawsuit brought by current and former minor leaguers alleging the violation of various wage laws. Four days ago, it was revealed that the settlement totaled $185 million and included a stipulation that, going forward, teams will not be expressly forbidden as they had been previously from paying their minor leaguers outside the regular season.

On Monday, leaders of the Senate Judiciary Committee exploring the continued utility of MLBs unique antitrust exemption sent a letter to commissioner Rob Manfred asking him a series of probing questions about how it affects minor league baseball in particular. The letter, which comes after a similar inquiry was sent to a minor league advocacy group last month, indicates at least some interest in pursuing legislation to remove or limit the scope of that exemption. The league has a week to respond.

In response to the settlement, the league issued a statement explaining, among other things, that, We are only in the second year of a major overhaul of the 100-year-old player development system and have made great strides to improve the quality of life for minor-league players.

And in response to the letter from the Senate Judiciary Committee, the league issued a statement saying, among other things, that, We look forward to providing detailed information to the committee regarding baseballs limited antitrust exemption.

All of this represents a crescendo of frustration and desperation from minor leaguers who have long been paid reprehensibly low wages that MLB lobbied to legalize with the 2018 legislation, cravenly entitled Save Americas Pastime Act, that exempted minor leaguers from minimum wage and maximum hours requirements. Advocacy groups and articles about living conditions have shone a spotlight on the situation and brought criticism down on the league.

MLB commissioner Rob Manfred speaks during the 2022 MLB baseball draft, Sunday, July 17, 2022, in Los Angeles. (AP Photo/Jae C. Hong)

Ahead of 2021, minor league salaries were increased, but the number of jobs was slashed as the league eliminated more than 40 teams affiliations. And this year, MLB introduced a housing policy to eliminate a major source of stress and expense for players, but the rollout has been uneven and the reception mixed.

Story continues

Even with these improvements, players are paid only in season and those without any major league experience make between $4,800 and $14,700 annually.

And yet, asked whether the issue is that the owners cant afford to pay the minor leaguers a living wage, Manfred said Tuesday that he kind of reject[s] the premise of the question that minor league players are not paid a living wage.

He explained, I think that we've made real strides in the last few years in terms of what minor league players are paid even putting to one side the signing bonuses that many of them have already received. They receive housing, which obviously is another form of compensation. I just reject the premise of the question. I don't know what else to say about that."

Granted, a living wage is more subjective than the federal poverty line, which MLB clears only at the higher end of minor league salaries. A recent study proposed $35,000 for minor leaguers to put them in line with a living wage. An MIT calculator that takes into account local cost of living puts the cutoff for a single adult without children at $18.08 per hour in Maricopa County, Arizona where many teams complexes are located. Elsewhere in the country, that number is slightly lower or higher.

Of course, for minor leaguers, the issue is less about where their salaries fall in relation to what is considered the bare minimum and more about their pressing financial struggles and an inability to negotiate for a larger portion of the multibillion dollar industry.

I have very little doubt that Major League Baseball will give more carrots to minor league players to avoid structural change, Harry Marino, the executive director of Advocates for Minor Leaguers, said shortly before Manfred addressed the media. Free housing is great, except, guess what, if Major League Baseball wanted to take away free housing next year, they could.

Hours before MLB hosts the All-Star Game at Dodger Stadium, he considered whether the league is worried about the status of the antitrust exemption that makes such unilaterality possible and benevolence necessary.

I think the league is very nervous, Marino said. And I think with good reason.

Read this article:

MLB commissioner Rob Manfred rejects the premise that minor leaguers aren't paid a living wage - Yahoo Sports

Death, taxes and turnover among teams that make the playoffs in the NFL on a year-by-year basis. Those are the only guarantees in life.

Over the last 10 years, we've seen an average of 5.8 teams per year make the playoffs that didn't qualify for the postseason the prior year. Every year during that time, at least four teams made the jump from non-playoff team to playoff team. In years like 2017-18, we've seen that number as high as eight teams. The expanded playoffs implemented two seasons ago haven't changed the calculus either. Each of the last two years have seen seven teams make the playoffs after missing the season prior.

Sure, there are teams that make the playoffs on a consistent basis. New England has made the playoffs in nine of the past 10 seasons. For Green Bay and Kansas City, it's been eight of 10 years. However, for the most part, there's turnover. Since the 2012-13 season, 46.7 percent of playoff teams missed the season prior. Rosters change, there's plenty of parity in the league, and let's be honest, there's definitely some randomness involved when teams play only 17 games.

Based on history, we can expect at least four, and probably six or seven teams to go from in the playoffs to out of the playoffs and vice versa. Let's take a look at the betting odds at BetMGM to see which teams are most likely to fall out, and which teams are most likely to take their place.

Which teams that made the playoffs last season are most likely to miss the playoffs this season according to the oddsmakers?

Pittsburgh Steelers (+300 to make playoffs, 25% chance): The Ben Roethlisberger era in Pittsburgh is over. The team has been turned over to the combination of Mitch Trubisky and Kenny Pickett. We know all about Mike Tomlin's track record and the fact he's never had a losing season, but the betting odds are telling you it might be a down year in the Steel City.

Las Vegas Raiders (+180 to make playoffs, 35.7% chance): The Raiders made the playoffs last season, hired one of the brightest offensive minds in the game in Josh McDaniels as their head coach and traded for arguably the best wide receiver in football in Davante Adams. Despite all of that, they're sizable favorites to miss the playoffs this season. The AFC is loaded, and in particular, the AFC West will be a gauntlet.

New England Patriots (+135 to make playoffs, 42.6% chance): While everyone in the AFC loaded up and stockpiled weapons, the Patriots had a quiet offseason. Is Davante Parker enough for Mac Jones to continue to develop? And just how high is Jones' ceiling? If we've learned anything, it's be careful when betting against Bill Belichick.

Arizona Cardinals (-105 to make playoffs, 51.2% chance): Well, at least the quarterback drama is over with. However, DeAndre Hopkins is suspended for six games and we saw this team struggle down the stretch last season without him. That embarrassing playoff performance against the Rams has people wary of the Cardinals this season.

Tennessee Titans (-115 to make playoffs, 53.5% chance): Speaking of bad playoff performances changing the perception of teams, the Tennessee Titans round out the top five here. Tennessee was the No. 1 seed in the AFC last year, but fell flat on their face against the Bengals in the divisional round. Derrick Henry is another year older, A.J. Brown is gone and Ryan Tannehill is hard to trust.

Story continues

The rest of the teams: Cincinnati (-140, 58.3% chance), Philadelphia (-160, 61.5% chance), Kansas City (-200, 66.7% chance), San Francisco (-225, 69.2% chance), LA Rams (-250, 71.4% chance), Dallas (-300, 75% chance), Green Bay (-450, 81.8% chance), Buffalo (-550, 84.6% chance), Tampa Bay (-600, 85.7% chance)

Of all NFL playoff teams from last season, the Steelers have the worst odds to make it back this year. (Scott Winters/Icon Sportswire via Getty Images)

If teams are going to fall out of the playoffs, there's going to be teams that take their place. Which teams are most likely to make the jump, according to the betting odds?

NOTE: There are no odds available for the Cleveland Browns due to the uncertainty with Deshaun Watson. If he isn't suspended or gets a light suspension, Cleveland is probably near the top of this list. If he's suspended for a lengthy amount of time, the Browns have little chance. With that much variance, oddsmakers have kept Cleveland off the board for most of the offseason.

Indianapolis Colts (-190 to make playoffs, 65.5% chance): The Titans are on the previous list, and someone has to win the AFC South and therefore automatically qualify for the playoffs. After adding Matt Ryan, the Colts are now favored to win the division. Even if Tennessee holds onto the division crown, the Colts should be in the mix for a wild-card spot.

Baltimore Ravens (-165 to make playoffs, 62.3% chance): The Ravens made the playoffs the three prior seasons before last year, and they were 8-3 last year before injuries to Lamar Jackson and others derailed their season down the stretch. The Ravens should be healthier and they are the betting favorites to win the AFC North.

Los Angeles Chargers (-150 to make playoffs, 60% chance): The Chargers let a chance to make the playoffs last season slip away on the final snap of the NFL regular season. Justin Herbert is elite and another year older. With additions like Khalil Mack and J.C. Jackson, the defense is much improved. It should be a good year for the Chargers. But let's remember, it's the Chargers.

Denver Broncos (-140 to make playoffs, 58.3% chance): Denver acquired Russell Wilson in the offseason to greatly improve their roster and outlook for the upcoming season. The issue is that the AFC is loaded, and the AFC West in particular stands out. There will be a lot of competition in that division and wild-card race. Does Denver get it done?

Minnesota Vikings (-105 to make playoffs, 51.2% chance): Kevin O'Connell is another branch off the Sean McVay coaching tree, and there's hope that he better utilizes Minnesota's weapons than Mike Zimmer and company did. Justin Jefferson, Adam Thielen and Dalvin Cook make up one of the better group of weapons in the NFL.

Honorable mentions: Miami (+135, 42.6% chance), New Orleans (+135, 42.6% chance), Washington (+150, 40% chance)

More here:

NFL betting: Which playoff teams from last year will miss this year? - Yahoo Sports

Less than two weeks into its soft launch, GameStops NFT marketplace is already courting controversy. Among the NFTs listed on the platform is an artwork called Falling Man that was spotted by Web3 is Going Great. Theres no mistaking it, the NFT references one of the most iconic photos of the early 21st century. The Falling Man is part of a series of images captured by Associated Press photojournalist Richard Drew on the morning of September 11th, 2001. Of the 2,753 people who died inside the World Trade Center and surrounding area that day, its estimated that at least 100 individuals fell to their death while the towers were still standing.

This one probably fell from the MIR station, says the NFTs description, referencing Russias decommissioned space station. The artworks creator is selling two different versions of Falling Man, with the cheapest listed at 0.65 Ethereum or about $990. As Web3 is Going Great points out, GameStop operates a curated NFT marketplace. Artists must apply and pass a vetting process before they can list their tokens for sale. The company takes a 2.25 percent cut of sales. GameStop did not immediately respond to Engadgets comment request.

Artistic theft is a major issue in the NFT space. On platforms like OpenSea where people can mint tokens for free, fake and plagiarized content abounds. While you could make the argument that Falling Man doesnt fall into those categories and that artists should be free to reference past works and tragedies, its also true that this NFT trivializes the falling mans fate, reducing his final moments into something to be sold for a profit.

Update 07/24/22 9:00AM ET: The Falling Man NFT is no longer listed on GameStop's marketplace. The company has yet to return Engadget's request for comment or tweet about the takedown. However, in a direct message to one individual, the company said it was taking action against the creator of the NFT. "This NFT will be removed from our marketplace entirely," the company said. "This user has already had their minting ability removed from their account, and we have already been in direct contact with the creator about these actions."

Read more from the original source:

GameStop is letting someone sell an NFT that references a famous 9/11 photo (updated) - Yahoo Finance

CHICAGO, July 24, 2022 /PRNewswire/ -- At the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care. From July 24-28 in Chicago, the meeting's 250-plus sessions will deliver insights on a broad range of timely healthcare topics. Highlights include discussions exploring the use of artificial intelligence (AI) in personalized medicine, advances in multiplexed genomic sequencing and imaging, real-life applications of human brain organogenesis, how to build trust with patients, and guiding clinical decisions with mass spectrometry.

(PRNewsfoto/AACC)

AI in Personalized Medicine. Precision medicine involves tailoring treatments to individual patients and, increasingly, clinicians are using AI in their clinical prediction models to do this. In the meeting's opening keynote, Dr. Lucila Ohno-Machado, health associate dean of informatics and technology at the University of California San Diego, will introduce how AI models are developed, tested, and validated as well as performance measures that may help clinicians select these models for routine use.

Multiplexed Genomic Sequencing and Imaging. Thanks to advances in multiplexed genomic sequencing and imaging, we can identify small but crucial differences in DNA, RNA, proteins, and more. These techniques have also undergone a 50-million-fold reduction in cost and comparable improvements in quality since they first emerged. In spite of this, healthcare is just beginning to catch up with the implications of these technologies. Dr. George Church, AACC's 2022 Wallace H. Coulter Lectureship Awardee and founding core faculty and lead at the Synthetic Biology Wyss Institute at Harvard University, will discuss advances and implications of multiplex technologies at this plenary session.

Applications of Human Brain Organoid Technology. The human brain is a very complex biological system and is susceptible to several neurological and neurodegenerative disorders that affect millions of people worldwide. In this plenary session, Dr. Alysson R. Muotri, professor of cellular and molecular medicine at the University of California San Diego School of Medicine, will explore the concept of human brain organogenesis, or how to recreate the human brain in a dish. Several applications of this technology in neurological care will be discussed.

Story continues

Building Trust in Healthcare. The world is having a trust crisis that is affecting healthcare delivery across the globe. Dr. Thomas Lee, chief medical officer of Press Ganey Associates and professor of health policy and management at the Harvard T.H. Chan School of Public Health, will describe the importance of building trust among patients and healthcare workers in this plenary session. He will explore a three-component model for building trust, and the types of interventions most likely to be effective.

Guiding Clinical Decisions with Mass Spectrometry. In this, the meeting's closing keynote, Dr. Livia Schiavinato Eberlin, associate professor of surgery and director of translational and innovations research at Baylor College of Medicine, will discuss the development and application of direct mass spectrometry techniques used in clinical microbiology labs, clinical pathology labs, and the operating room. The presentation will focus on results obtained in ongoing clinical studies employing two direct mass spectrometry techniques, desorption electrospray ionization mass spectrometry imaging and the MasSpec Pen technology.

Additionally, at the Clinical Lab Expo, more than 750 exhibitors will display innovative technologies that are just coming to market in every clinical lab discipline.

"Laboratory medicine's capacity to adapt to changing healthcare circumstances and use the field's scientific insights to improve quality of life is unparalleled. This capacity is constantly growing, with cutting-edge diagnostic technologies emerging every day in areas as diverse as mass spectrometry, artificial intelligence, genomic sequencing, and neurology," said AACC CEO Mark J. Golden. "The 2022 AACC Annual Scientific Meeting will shine a light on the pioneers in laboratory medicine who are mobilizing these new advances to enhance patient care."

Session Information

AACC Annual Scientific Meeting registration is free for members of the media. Reporters can register online here: https://www.xpressreg.net/register/aacc0722/media/landing.asp

AI in Personalized Medicine

Session 11001 Biomedical Informatics Strategies to Enhance Individualized Predictive ModelsSunday, July 245-6:30 p.m.U.S. Central Time

Multiplexed Genomic Sequencing and Imaging

Session 12001 Multiplexed and Exponentially Improving TechnologiesMonday, July 258:45 10:15 a.m.U.S. Central Time

Applications of Human Brain Organoid Technology

Session 13001 Applications of Human Brain Organoid TechnologyTuesday, July 268:45 10:15 a.m.U.S. Central Time

Building Trust in Healthcare

Session 14001 Building Trust in a Time of TurmoilWednesday, July 278:45 10:15 a.m.U.S. Central Time

Guiding Clinical Decisions with Mass Spectrometry

Session 15001 Guiding Clinical Decisions with Molecular Information provided by Direct Mass Spectrometry TechnologiesThursday, July 288:45 10:15 a.m.U.S. Central Time

All sessions will take place in Room S100 of the McCormick Place Convention Center in Chicago.

About the 2022 AACC Annual Scientific Meeting & Clinical Lab ExpoThe AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 24-28. Plenary sessions will explore artificial intelligence-based clinical prediction models, advances in multiplex technologies, human brain organogenesis, building trust between the public and healthcare experts, and direct mass spectrometry techniques.

At the AACC Clinical Lab Expo, more than 750 exhibitors will fill the show floor of the McCormick Place Convention Center in Chicago with displays of the latest diagnostic technology, including but not limited to COVID-19 testing, artificial intelligence, mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.

About AACCDedicated to achieving better health through laboratory medicine, AACC brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit http://www.aacc.org.

Christine DeLongAACCSenior Manager, Communications & PR(p) 202.835.8722cdelong@aacc.org

Molly PolenAACCSenior Director, Communications & PR(p) 202.420.7612(c) 703.598.0472mpolen@aacc.org

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/artificial-intelligence-in-personalized-medicine-genomic-sequencing-advances-human-brain-organogenesis-building-trust-with-patients-guiding-patient-decisions-with-mass-spectrometry-and-much-more-to-be-explored-at-the-2022-aac-301592069.html

SOURCE AACC

View post:

Artificial Intelligence in Personalized Medicine, Genomic Sequencing Advances, Human Brain Organogenesis, Building Trust with Patients, Guiding...